» Articles » PMID: 28702192

Freezing of Gait is an Early Clinical Feature of Progressive Supranuclear Palsy

Overview
Specialty Neurology
Date 2017 Jul 14
PMID 28702192
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: Early clinical diagnosis of progressive supranuclear palsy (PSP) remains challenging.

Aim: We attempted to identify any sign or symptom to diagnose PSP earlier.

Methods: A total of 401 patients, 40 with PSP and 361 with other neurodegenerative disorders, were included. We followed these patients for at least 1 year since 2009. We reviewed the signs and symptoms of patients with PSP in a standardized manner, and observed four manifestations: "vertical supranuclear gaze abnormality," "movement disorders," "pseudobulbar palsy" and "dementia of frontal type." Features, such as symmetric parkinsonism, freezing of gait, postural instability, dysarthria and/or dysphagia, or dementia of frontal type, were considered core clinical features.

Results: In patients with PSP, "movement disorders" was the most common manifestation, whereas "vertical supranuclear gaze abnormality" was uncommon during the early disease course. A total of 16 patients fulfilled the National Institute for Neurological Disorders and Stroke and Society for PSP criteria for possible PSP at their first clinic visit. Of the remaining 24 patients, 15 presented with one or more core clinical features before fulfilling the criteria for possible PSP; nine patients had a clinical diagnosis of PSP but never fulfilled the criteria. A total of 49 of the 361 patients with other neurodegenerative disorders had core clinical features. A comparison showed that freezing of gait differentiated the groups the best over the disease course.

Conclusion: Freezing of gait is an early feature that might improve the clinical diagnosis of PSP, whereas vertical supranuclear gaze abnormality is not.

Citing Articles

Balance and gait in progressive supranuclear palsy: a narrative review of objective metrics and exercise interventions.

Dale M, Silva-Batista C, de Almeida F, Horak F Front Neurol. 2023; 14:1212185.

PMID: 37426438 PMC: 10327556. DOI: 10.3389/fneur.2023.1212185.


Relationships between Freezing of Gait Severity and Cognitive Deficits in Parkinson's Disease.

Scholl J, Espinoza A, Rai W, Leedom M, Baugh L, Berg-Poppe P Brain Sci. 2021; 11(11).

PMID: 34827496 PMC: 8615553. DOI: 10.3390/brainsci11111496.


Freezing of Gait in Parkinson's Disease: Invasive and Noninvasive Neuromodulation.

Rahimpour S, Gaztanaga W, Yadav A, Chang S, Krucoff M, Cajigas I Neuromodulation. 2020; 24(5):829-842.

PMID: 33368872 PMC: 8233405. DOI: 10.1111/ner.13347.


Freezing of gait in Parkinson's disease: pathophysiology, risk factors and treatments.

Gao C, Liu J, Tan Y, Chen S Transl Neurodegener. 2020; 9:12.

PMID: 32322387 PMC: 7161193. DOI: 10.1186/s40035-020-00191-5.


Gait Ignition Failure in JNPL3 Human Tau-mutant Mice.

Jang H, Ryu J, Shin K, Seo N, Kim G, Huh Y Exp Neurobiol. 2019; 28(3):404-413.

PMID: 31308799 PMC: 6614071. DOI: 10.5607/en.2019.28.3.404.


References
1.
Hughes A, Daniel S, Kilford L, Lees A . Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992; 55(3):181-4. PMC: 1014720. DOI: 10.1136/jnnp.55.3.181. View

2.
Respondek G, Roeber S, Kretzschmar H, Troakes C, Al-Sarraj S, Gelpi E . Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy. Mov Disord. 2013; 28(4):504-9. DOI: 10.1002/mds.25327. View

3.
Kanazawa M, Shimohata T, Toyoshima Y, Tada M, Kakita A, Morita T . Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study. Mov Disord. 2009; 24(9):1312-8. DOI: 10.1002/mds.22583. View

4.
Factor S . The clinical spectrum of freezing of gait in atypical parkinsonism. Mov Disord. 2008; 23 Suppl 2:S431-8. DOI: 10.1002/mds.21849. View

5.
Gilman S, Wenning G, Low P, Brooks D, Mathias C, Trojanowski J . Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008; 71(9):670-6. PMC: 2676993. DOI: 10.1212/01.wnl.0000324625.00404.15. View